Nomograms for predicting disease progression in patients of Stage I non-small cell lung cancer treated with stereotactic body radiotherapy.

about

Nomograms for predicting disease progression in patients of Stage I non-small cell lung cancer treated with stereotactic body radiotherapy.

Item

http://www.wikidata.org/entity/Q49666975

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Nomograms for predicting disea ...... tereotactic body radiotherapy.

@en

Nomograms for predicting disea ...... tereotactic body radiotherapy.

@nl

type

Item

label

Nomograms for predicting disea ...... tereotactic body radiotherapy.

@en

Nomograms for predicting disea ...... tereotactic body radiotherapy.

@nl

prefLabel

Nomograms for predicting disea ...... tereotactic body radiotherapy.

@en

Nomograms for predicting disea ...... tereotactic body radiotherapy.

@nl

P1476

Nomograms for predicting disea ...... tereotactic body radiotherapy.

@en

P2093

Jian He

http://www.w3.org/2001/XMLSchema#string

Luxi Ye

http://www.w3.org/2001/XMLSchema#string

Shiming Shi

http://www.w3.org/2001/XMLSchema#string

Yan Huang

http://www.w3.org/2001/XMLSchema#string

Yong Hu

http://www.w3.org/2001/XMLSchema#string

Zhaochong Zeng

http://www.w3.org/2001/XMLSchema#string

P2860

Primary tumor standardized uptake value measured on F18-Fluorodeoxyglucose positron emission tomography is of prediction value for survival and local control in non-small-cell lung cancer receiving radiotherapy: meta-analysis

Stereotactic ablative radiotherapy for early stage non-small cell lung cancer: A critical literature review of predictive factors of relapse.

Fluorodeoxyglucose positron emission tomography and tumor marker expression in non-small cell lung cancer.

CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma

Fluorodeoxyglucose positron emission tomography and chemotherapy-related tumor marker expression in non-small cell lung cancer.

Relationship between tumor size and survival in non-small-cell lung cancer (NSCLC): an analysis of the surveillance, epidemiology, and end results (SEER) registry

Predicting Overall Survival After Stereotactic Ablative Radiation Therapy in Early-Stage Lung Cancer: Development and External Validation of the Amsterdam Prognostic Model.

Ablative Tumor Radiation Can Change the Tumor Immune Cell Microenvironment to Induce Durable Complete Remissions

Nomogram to predict the benefit of radiation for older patients with breast cancer treated with conservative surgery.

Prediction of occult lymph node metastasis using volume-based PET parameters in small-sized peripheral non-small cell lung cancer.

P304

160-166

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JJCO/HYX179

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29253245

http://www.w3.org/2001/XMLSchema#string